Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

A Member of the Law Professor Blogs Network

Wednesday, December 22, 2004

Buspar Drug Settlement in Antrust suits Against Bristol Myers Squib By States

Kansas, Idaho, Rhode Island, and Michigan are just four out of thirty-four states that have recently obtained settlements from Bristol Meyer Squib and Danville Pharmacal for violating the antitrust act in preventing the entry of generic alternatives to Buspar, an anti-anxiety drug.   In addition to a cash payment, the drug companies agree not to list in the FDA Orange Book Buspar or other patented drugs that may delay the entry of generics onto the market.

http://lawprofessors.typepad.com/antitrustprof_blog/2004/12/buspar_drug_set.html

| Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef00d8345281ca53ef

Listed below are links to weblogs that reference Buspar Drug Settlement in Antrust suits Against Bristol Myers Squib By States:

Comments

I recently received a check from Bristol Meyer Settlement regarding a class action suit. I am unaware of any class action suit that involves me. The letter does not indicate what the settlement was in relation to. Was it a drug? Please advise. I no longer have this information available to me.

Thank you for your time and response to this inquiry. The amount of the check was $380.87.

Dianna Johnson (912) 598-1159 Home#

Posted by: Dianna T Johnson | Aug 14, 2005 10:19:23 AM

Post a comment